These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 27540432)
1. Role of (18)F-FDG PET-CT in Monitoring the Cyclophosphamide Induced Pulmonary Toxicity in Patients with Breast Cancer - 2 Case Reports. Taywade SK; Kumar R; Bhethanabhotla S; Bal C Nucl Med Mol Imaging; 2016 Sep; 50(3):261-5. PubMed ID: 27540432 [TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003 [TBL] [Abstract][Full Text] [Related]
3. Early detection value of Zhao M; Zhang W Ann Hematol; 2019 Apr; 98(4):909-914. PubMed ID: 30460376 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Importance of Bone Marrow Uptake on Baseline Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313 [TBL] [Abstract][Full Text] [Related]
5. Impact of (18)f-fluorodeoxyglucose positron emission tomography/computed tomography scan on initial evaluation of head and neck squamous cell carcinoma: our experience at a tertiary care center in India. Nair S; Mohan S; Nilakantan A; Gupta A; Malik A; Gupta A World J Nucl Med; 2015; 14(1):19-24. PubMed ID: 25709540 [TBL] [Abstract][Full Text] [Related]
6. Pulmonary drug toxicity: FDG-PET findings in patients with lymphoma. Kazama T; Faria SC; Uchida Y; Ito H; Macapinlac HA Ann Nucl Med; 2008 Feb; 22(2):111-4. PubMed ID: 18311535 [TBL] [Abstract][Full Text] [Related]
7. Obert J; Vercellino L; Van Der Gucht A; de Margerie-Mellon C; Bugnet E; Chevret S; Lorillon G; Tazi A Eur J Nucl Med Mol Imaging; 2017 Apr; 44(4):598-610. PubMed ID: 27645693 [TBL] [Abstract][Full Text] [Related]
8. Whole-body Gajjala SR; Hulikal N; Kadiyala S; Kottu R; Kalawat T Indian J Med Res; 2018 Mar; 147(3):256-262. PubMed ID: 29923514 [TBL] [Abstract][Full Text] [Related]
9. PET/CT with 18F-FDG- and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis. Bondue B; Sherer F; Van Simaeys G; Doumont G; Egrise D; Yakoub Y; Huaux F; Parmentier M; Rorive S; Sauvage S; Lacroix S; Vosters O; De Vuyst P; Goldman S J Nucl Med; 2015 Jan; 56(1):127-32. PubMed ID: 25537989 [TBL] [Abstract][Full Text] [Related]
11. Can Gupta M; Datta A; Choudhury PS; Dsouza M; Batra U; Mishra A World J Nucl Med; 2017; 16(2):133-139. PubMed ID: 28553180 [TBL] [Abstract][Full Text] [Related]
12. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring. Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705 [TBL] [Abstract][Full Text] [Related]
13. Indeterminate pulmonary nodules on CT images in breast cancer patient: the additional value of 18F-FDG PET/CT. Evangelista L; Panunzio A; Cervino AR; Vinante L; Al-Nahhas A; Rubello D; Muzzio PC; Polverosi R J Med Imaging Radiat Oncol; 2012 Aug; 56(4):417-24. PubMed ID: 22883649 [TBL] [Abstract][Full Text] [Related]
14. Different predictive values of interim Kim J; Lee JO; Paik JH; Lee WW; Kim SE; Song YS Ann Nucl Med; 2017 Jan; 31(1):1-11. PubMed ID: 27627889 [TBL] [Abstract][Full Text] [Related]
15. Apoptotic PET Imaging of Rat Pulmonary Fibrosis with Small-Molecule Radiotracer. Xiong Y; Nie D; Liu S; Ma H; Su S; Sun A; Zhao J; Zhang Z; Xiang X; Tang G Mol Imaging Biol; 2019 Jun; 21(3):491-499. PubMed ID: 30167994 [TBL] [Abstract][Full Text] [Related]